Table 2.
Associations of T2D pPS with baseline and 1-year baseline-adjusted values
| Outcome (N = 2,647) | β-Cell pPS | Proinsulin pPS | Obesity pPS | Lipodystrophy pPS | Liver/lipid pPS | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Estimate | P | Estimate | P | Estimate | P | Estimate | P | Estimate | P | |
| BMI, kg/m2 | ||||||||||
| Baseline | −0.6496 | 1.7 × 10−7 | −0.0301 | 0.814 | 0.2678 | 0.032 | −0.5483 | 1.3 × 10−5 | 0.0061 | 0.961 |
| 1-year adj baseline | 0.0519 | 0.21 | −0.0574 | 0.180 | −0.0303 | 0.470 | 0.0500 | 0.230 | −0.0204 | 0.620 |
| Waist, cm | ||||||||||
| Baseline | −1.2290 | 1.1 × 10−5 | −0.0299 | 0.918 | 0.6096 | 0.030 | −1.4584 | 2.5 × 10−7 | 0.1025 | 0.715 |
| 1-year adj baseline | 0.1025 | 0.43 | 0.0076 | 0.960 | −0.0568 | 0.660 | 0.2432 | 0.070 | −0.2308 | 0.080 |
| Triglycerides, mg/dL | ||||||||||
| Baseline | −2.8280 | 0.128 | 0.3748 | 0.845 | 0.8656 | 0.641 | 4.0744 | 0.030 | −9.3715 | 3.9 × 10−7 |
| 1-year adj baseline | 1.5997 | 0.23 | 0.1291 | 0.930 | 1.6676 | 0.210 | 1.5290 | 0.260 | −4.3715 | 1.0 × 10−3 |
| HbA1c | ||||||||||
| Baseline, % | −0.0006 | 0.943 | 0.0160 | 0.104 | −0.0067 | 0.491 | 0.0075 | 0.430 | 0.0058 | 0.530 |
| Baseline, mmol/mol | −23.504 | −23.3220 | −23.571 | −23.4150 | −23.434 | |||||
| 1-year adj baseline, % | 0.0066 | 0.33 | 0.0000 | 0.990 | 0.0055 | 0.410 | 0.0026 | 0.680 | −0.0108 | 0.100 |
| 1-year adj baseline, mmol/mol | −23.425 | −23.4970 | −23.437 | −23.4690 | −23.615 | |||||
| Fasting insulin, μU/mL | ||||||||||
| Baseline | −1.2027 | 4.6 × 10−5 | −0.6455 | 0.034 | −0.4197 | 0.157 | 0.4934 | 0.100 | 0.2062 | 0.486 |
| 1-year adj baseline | −0.3308 | 0.23 | 0.1283 | 0.670 | 0.7801 | 0.010 | 0.0399 | 0.890 | 0.1962 | 0.490 |
| PIR | ||||||||||
| Baseline | 0.0101 | 8.9 × 10−5 | −0.0045 | 0.078 | −0.0051 | 0.048 | 0.0000 | 0.972 | −0.0015 | 0.587 |
| 1-year adj baseline | 0.0042 | 0.14 | 0.0017 | 0.560 | −0.0029 | 0.326 | 0.0013 | 0.690 | −0.0038 | 0.190 |
| ISI | ||||||||||
| Baseline | 0.0054 | 0.04 | 0.0050 | 0.061 | 0.0025 | 0.295 | −0.0070 | 0.007 | −0.0019 | 0.498 |
| 1-year adj baseline | 0.0048 | 0.10 | −0.0002 | 0.930 | −0.0004 | 0.850 | 0.0009 | 0.800 | −0.0035 | 0.190 |
| IGR (μU/mg) | ||||||||||
| Baseline | −9.1105 | 6.4 × 10−7 | −2.2354 | 0.244 | −3.1251 | 0.090 | 2.9536 | 0.113 | 1.5114 | 0.411 |
| 1-year adj baseline | −8.4978 | 5.6 × 10−6 | −2.7241 | 0.160 | 0.2252 | 0.910 | −0.0259 | 0.100 | 0.1498 | 0.940 |
| CIR | ||||||||||
| Baseline | −0.0465 | 1.5 × 10−8 | −0.0155 | 0.073 | −0.0114 | 0.178 | 0.0149 | 0.072 | −0.0008 | 0.913 |
| 1-year adj baseline | −0.0417 | 9.6 × 10−7 | −0.0108 | 0.230 | 0.0042 | 0.630 | −0.0035 | 0.700 | 0.0027 | 0.760 |
Estimates are reported per SD. The outcome value at year 1 includes adjustment for the respective trait measurement at baseline (1-year adj baseline).
P values in boldface type indicate significant replication (P < 0.05) for associations with baseline measures and study-wide significant (P < 0.001) for 1 year adjusted for baseline. For baseline, results are reported in natural log transformation scale. For all 1-year baseline-adjusted results, the original scale was used for point estimates (no log transformation).